drugset / Trial / NCT00352612
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
Phase 4
Completed
200 enrolled
Aaron Chen
Johns Hopkins University · collabThrasher Research Fund · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to help define the role of antibiotics in the treatment of pediatric skin infections caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). The investigators hypothesize that treatment with cephalexin, a penicillin-like antibiotic to which CA-MRSA would be expected to be resistant, does not result in poorer outcomes than treatment with clindamycin, an antibiotic to which CA-MRSA is most often susceptible.
Timeline
- Start
- 2006-09
- Primary completion
- 2009-05
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CEPHALEXIN ANHYDROUS | Small molecule | 40 mg/kg | Oral |
| Comparator | Clindamycin | Unknown | 20 mg/kg | Oral |